_____________________________________________________________________
INNOVATE RETINA TV
_____________________________________________________________________
LATE-BREAKING CLINICAL TRIAL DATA
Diana V. Do, MD and colleagues discuss late-breaking data from the LIGHTSIGHT III
clinical trial on photobiomodulation (PBM) in dry AMD, with a high-level overview of PBM technology.
LATE-BREAKING CLINICAL TRIAL DATA
Will this technology provide meaningful improvements in patients’ vision?
EXPERTS WEIGH IN ON NEW DATA
Hear what the experts have to say live from the Retina Society Meeting in this 5-minute video.
KOL INTERVIEWS
KOL VIDEOS live from the Retina Society Meeting in this 15-minute video.
OAKS and DERBY: Efficacy and Safety Data Summary
OAKS and DERBY: Efficacy and Safety Data Summary live from the Retina Society Meeting in this 11-minute video.
Stay Informed
Can't make this event? Subscribe here to stay informed on all upcoming events!